<DOC>
	<DOCNO>NCT02209064</DOCNO>
	<brief_summary>Prospective non-randomized , single arm trial evaluate safety performance EpiAccess , study device , gain access normal , non-distended pericardial space epicardial diagnostic therapeutic ( ablation ) procedure .</brief_summary>
	<brief_title>`` EASE '' Epicardial Access With EpiAccess System</brief_title>
	<detailed_description>Prior enrolment , patient evaluate basis late available data establish eligibility . Eligible patient enrol study local principal investigator inform consent obtain . As EpiAccess use access portion electrophysiology procedure , safety , performance effectiveness endpoint acute time needle insertion pericardial space access ( guidewire insertion pericardial sac ) . Patients follow hospital discharge . Follow-up clinical examination perform accordance institution ' standard care . No special test require device . Patients ' completion study occur time hospital discharge , earlier patient complete study . The stop criterion study : great 25 % Serious Adverse Device Effect , define protocol , enrolment 10 patient , compare exist data literature present epicardial access procedure result sub-xyphoid ( minimally invasive ) surgical procedure .</detailed_description>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>1 . Patient 18 year age old 2 . Pericardial access clinically indicate 3 . Patient willing able provide write informed consent 1 . Patient history cardiac pericardial surgery past 6 month 2 . Patient history chronic pericarditis 3 . Myocardial infarction within 4 week prior procedure 4 . Class IV NYHA ( New York Heart Association ) heart failure symptoms 5 . Cerebrovascular accident within previous 6 month 6 . Known carotid artery stenosis great 80 % 7 . Presence thrombus leave atrium 8 . Coagulopathy 9 . Severe Hepatic Dysfunction Enlargement 10 . Life expectancy le 6 month 11 . BMI &gt; 40 12 . Patient enrol another clinical trial 13 . Patient pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Subxiphoid</keyword>
	<keyword>Access</keyword>
</DOC>